Check Point Software Technologies (CHKP) stock has seen subtle shifts over the past week, catching some investor attention. Share performance remains broadly stable this month, even though there has been recent softness compared to prior quarters. This has prompted questions about longer-term momentum.

See our latest analysis for Check Point Software Technologies.

The latest dip in Check Point Software Technologies’ share price, despite a strong multi-year run, suggests momentum is tapering off. The 1-year total shareholder return of -5.99% contrasts with robust gains of 74% and 54.6% over three and five years respectively. Shorter-term price swings hint at shifting sentiment as investors weigh near-term softness against long-term growth.

If you’re watching the tech sector for fresh ideas, now’s the perfect time to discover See the full list for free..

With Check Point now trading around 14% below consensus analyst price targets and steady revenue and profit growth over the past year, investors have to wonder whether there is still an upside left, or if future gains are already reflected in the current price.

With Check Point Software Technologies trading at $195.56, the most widely watched narrative estimates fair value at $223.05, a notable premium to the latest close. This narrows the gap between current market sentiment and what is priced in by consensus projections, encouraging a deeper look at what supports this assessment.

The Infinity platform continues to gain traction, with strong double-digit revenue growth and increased customer adoption, now accounting for over 15% of total revenue. This supports expectations for revenue growth through enhanced customer retention and cross-selling opportunities.

Read the complete narrative.

Curious what’s powering this bullish stance? The narrative banks on sharp adoption trends and ambitious targets for future growth. But which margin forecasts and revenue leaps really anchor that fair value? Click through to see the catalysts and precise targets driving this price projection.

Result: Fair Value of $223.05 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, risks such as competitive pressure in emerging technologies and macroeconomic uncertainty could quickly undermine current growth expectations.

Find out about the key risks to this Check Point Software Technologies narrative.

While analyst consensus suggests Check Point Software Technologies is undervalued, our SWS DCF model tells a different story. According to the DCF estimate, shares trade above fair value. This suggests the market has already priced in much of the company’s future growth. Could this signal caution for value-seeking investors?

Look into how the SWS DCF model arrives at its fair value.

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Check Point Software Technologies for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover undervalued stocks based on their cash flows. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

If you see the story differently or want to dig into the numbers yourself, you can shape your own perspective in under three minutes with Do it your way.

A good starting point is our analysis highlighting 4 key rewards investors are optimistic about regarding Check Point Software Technologies.

Smart investors know the biggest opportunities often hide in plain sight. Don’t wait until the headlines catch up. These handpicked stock ideas can help shape your portfolio’s future.

Unlock growth potential by choosing from these 891 undervalued stocks based on cash flows to see which companies offer real value based on their cash flows and fundamentals.

Maximize your income with 3%;elm:context_link;itc:0;sec:content-canvas\\" class=\\"link \\">these 19 dividend stocks with yields > 3%, featuring stocks with yields that outpace the market and reward you for staying invested.

Tap into breakthroughs in medicine with these 33 healthcare AI stocks to target the innovators transforming healthcare with artificial intelligence.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include CHKP.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com